Literature DB >> 10885210

Randomized controlled trial and economic evaluation.

S Jain1, N K Arora.   

Abstract

Conducting economic evaluation alongside clinical trials is an efficient way of getting valid and reliable information with minimum assumptions made during data collection. However, design of a randomised control trial (RCT) takes away several of the real world situations, the variations in resource utilisation, their cost due to close supervision and monitoring of the study subjects. Suitable sensitivity analysis has to be done to make the economic data obtained more pragmatic and hence utilised by the policy makers.

Mesh:

Year:  2000        PMID: 10885210     DOI: 10.1007/BF02820689

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

Review 1.  Making cost assessments based on RCTs more useful to decision-makers.

Authors:  R Baltussen; A Ament; R Leidl
Journal:  Health Policy       Date:  1996-09       Impact factor: 2.980

Review 2.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies.

Authors:  J A Barber; S G Thompson
Journal:  BMJ       Date:  1998-10-31

3.  Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance.

Authors:  C Donaldson; V Hundley; E McIntosh
Journal:  Health Econ       Date:  1996 May-Jun       Impact factor: 3.046

4.  From efficacy to cost-effectiveness.

Authors:  S Thompson; J Barber
Journal:  Lancet       Date:  1997-12-13       Impact factor: 79.321

Review 5.  Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?

Authors:  B O'Brien
Journal:  Med Care       Date:  1996-12       Impact factor: 2.983

6.  Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial.

Authors:  K A Schulman; M Buxton; H Glick; M Sculpher; G Guzman; J Kong; M Backhouse; J Mauskopf; L Bell; J M Eisenberg
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

Review 7.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.

Authors:  A Briggs; M Sculpher; M Buxton
Journal:  Health Econ       Date:  1994 Mar-Apr       Impact factor: 3.046

8.  Economic analysis and clinical trials.

Authors:  M F Drummond; G L Stoddart
Journal:  Control Clin Trials       Date:  1984-06

9.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Authors:  D B Mark; M A Hlatky; R M Califf; C D Naylor; K L Lee; P W Armstrong; G Barbash; H White; M L Simoons; C L Nelson
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

10.  Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice.

Authors:  G Oster; G M Borok; J Menzin; J F Heyse; R S Epstein; V Quinn; V Benson; R J Dudl; A M Epstein
Journal:  Arch Intern Med       Date:  1996-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.